ISOCITRATE DEHYDROGENASE GENE MUTATION
Clinical trials for ISOCITRATE DEHYDROGENASE GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ISOCITRATE DEHYDROGENASE GENE MUTATION trials appear
Sign up with your email to follow new studies for ISOCITRATE DEHYDROGENASE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in people with advanced solid tumors that have a specific genetic change (IDH mutation). The main goals were to find a safe dose and check for side effects. The study was stopped early, so results are limited.
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental IDH drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in 46 adults with advanced blood cancers that have a specific genetic change (IDH mutation). The main goals were to find a safe dose and check for side effects. The study was stopped early, so results are limited,…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 14, 2026 12:04 UTC